BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35259773)

  • 1. Vascular endothelial growth factor-C modulates cortical NMDA receptor activity in cortical lesions of young patients and rat model with focal cortical dysplasia.
    Shen KF; Duan QT; Duan W; Xu SL; An N; Ke YY; Wang LT; Liu SY; Yang H; Zhang CQ
    Brain Pathol; 2022 Sep; 32(5):e13065. PubMed ID: 35259773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB.
    Boer K; Troost D; Spliet WG; van Rijen PC; Gorter JA; Aronica E
    Acta Neuropathol; 2008 Jun; 115(6):683-96. PubMed ID: 18317782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Expression of VEGF-C and Its Receptors, VEGFR-2 and VEGFR-3, in Patients with Mesial Temporal Lobe Epilepsy.
    Sun FJ; Wei YJ; Li S; Guo W; Chen X; Liu SY; He JJ; Yin Q; Yang H; Zhang CQ
    J Mol Neurosci; 2016 Jun; 59(2):241-50. PubMed ID: 26798047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
    Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
    Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and cellular distribution of vascular endothelial growth factor-C system in cortical tubers of the tuberous sclerosis complex.
    Zhang CQ; Shu HF; Yin Q; An N; Xu SL; Yin JB; Song YC; Liu SY; Yang H
    Brain Pathol; 2012 Mar; 22(2):205-18. PubMed ID: 21767323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of pannexin 1 and 2 in cortical lesions from intractable epilepsy patients with focal cortical dysplasia.
    Li S; Zang Z; He J; Chen X; Yu S; Pei Y; Hou Z; An N; Yang H; Zhang C; Liu S
    Oncotarget; 2017 Jan; 8(4):6883-6895. PubMed ID: 28036289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiles of α-synuclein in cortical lesions of patients with FCD IIb and TSC, and FCD rats.
    Zhang L; Huang J; Dai L; Zhu G; Yang XL; He Z; Li YH; Yang H; Zhang CQ; Shen KF; Liang P
    Front Neurol; 2023; 14():1255097. PubMed ID: 38020594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Sun FJ; Zhang CQ; Chen X; Wei YJ; Li S; Liu SY; Zang ZL; He JJ; Guo W; Yang H
    J Neuroinflammation; 2016 Apr; 13(1):85. PubMed ID: 27095555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
    Guo W; Zhang CQ; Shu HF; Yang MH; Yin Q; Yang H
    J Mol Neurosci; 2013 May; 50(1):7-13. PubMed ID: 22752548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-duration epilepsy affects cell morphology and glutamatergic synapses in type IIB focal cortical dysplasia.
    Finardi A; Colciaghi F; Castana L; Locatelli D; Marras CE; Nobili P; Fratelli M; Bramerio MA; Lorusso G; Battaglia GS
    Acta Neuropathol; 2013 Aug; 126(2):219-35. PubMed ID: 23793416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of the Plexin-B2 system in tuberous sclerosis complex and focal cortical dysplasia IIb lesions.
    Dai L; Huang J; Shen KF; Yang XL; Zhu G; Zhang L; Wang ZK; Liu SY; Liao X; Xu SL; Yang H; Li XY; Zhang CQ
    Histol Histopathol; 2024 Jan; ():18707. PubMed ID: 38293776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs).
    Sugiura C; Miyata H; Ueda M; Ohama E; Vinters HV; Ohno K
    Neuropathology; 2008 Aug; 28(4):372-81. PubMed ID: 18179408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of autophagy-related proteins in malformations of cortical development].
    Chen S; Piao Y; Fu Y; Li Z; Liu C; Lu D
    Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):305-9. PubMed ID: 26178210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research on distribution and expression of NMDA receptors and parvalbumin-positive neurons in intractable epilepsy-related focal cortical dysplasia].
    Liu L; Piao YS; Wang W; Chen L; Wei LF; Yang H; Lu DH
    Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):16-20. PubMed ID: 18509979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the Nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Yu SX; Li S; Shu HF; Zhang CQ; Liu SY; Yang H
    J Neuropathol Exp Neurol; 2012 Jul; 71(7):665-77. PubMed ID: 22710967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, imaging, and immunohistochemical characteristics of focal cortical dysplasia Type II extratemporal epilepsies in children: analyses of an institutional case series.
    Knerlich-Lukoschus F; Connolly MB; Hendson G; Steinbok P; Dunham C
    J Neurosurg Pediatr; 2017 Feb; 19(2):182-195. PubMed ID: 27885945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
    Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
    Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R
    Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.